Results 111 to 120 of about 33,581 (195)

Development of Glycoconjugated MAGL Inhibitors with Glucose-Dependent Antiproliferative Activity. [PDF]

Int J Mol Sci
Bononi G, Bertini F, Masoni S, Stefano MD, Mosca R, Felice F, Signore G, Minutolo F, Granchi C, Tuccinardi T, Di Bussolo V.   +10 more
europepmc   +1 more source

Biodegradation of polyethylene terephthalate microplastics by Paenibacillus naphthalenovorans PETKKU2: Response surface optimization and genomic evidence for an alternative degradation mechanism. [PDF]

PLoS One
Choonut A, Wongfaed N, Poolpol A, Boonlue S, Wantala K, Pinyakong O, Plangklang P, Reungsang A.   +7 more
europepmc   +1 more source

Urine bis(Monoacylglycerol)Phosphate and risk of freezing of gait in parkinson's disease. [PDF]

Sci Rep
Sang S, Yang N.
europepmc   +1 more source

Lipid metabolism reprogramming shapes the immune landscape in the tumor microenvironment. [PDF]

Cell Mol Immunol
Du YW, Cai ZR, Duan XT, Li XY, Yue T, Tian T, Li JJ, Ju HQ.   +7 more
europepmc   +1 more source

Investigation of the Efficacy and Mechanism of Monoacylglycerol Lipase Inhibitors in Diabetic Foot Ulcers. [PDF]

Pharmaceuticals (Basel)
Liang Z, Wang Y, Li M, Li H, Han Y, Zhao Y, Yang J, Tan Y, Dai G, Guo N, Yao J, Lu X, Zhang G.   +12 more
europepmc   +1 more source

Lipidomic profiling reveals systemic serum lipid remodeling induced by dexamethasone in mice. [PDF]

Front Mol Biosci
Zhang A, Wang Z, Ji J.
europepmc   +1 more source

Editorial: Regulation of inflammation: metabolic reprogramming and posttranslational modification. [PDF]

Front Immunol
Jiang Z, Li T, Bian J, Huai W.
europepmc   +1 more source

Notoginsenoside R1, a Metabolite from <i>Panax notoginseng</i>, Prevents Paclitaxel-Induced Peripheral Neuropathic Pain in Mice. [PDF]

Molecules
Al-Musailem M, Masocha W, Al-Romaiyan A.
europepmc   +1 more source

Plasma lipidomics, choline metabolites, and metabolic-associated steatotic liver disease (MASLD): A Coronary Artery Risk Development in Young Adults (CARDIA) study. [PDF]

PLoS One
Sprinkles JK, Qin Q, Steward C, Howard AG, Lulla A, Hullings AG, Carr JJ, Shaikh SR, Avery CL, North KE, Gordon-Larsen P, Meyer KA.   +11 more
europepmc   +1 more source

Expediting hit-to-lead progression in drug discovery through reaction prediction and multi-dimensional optimization. [PDF]

Nat Commun
Nippa DF, Atz K, Stenzhorn Y, Müller AT, Tosstorff A, Benz J, Binch H, Bürkler M, Haider A, Heer D, Hochstrasser R, Kramer C, Reutlinger M, Schneider P, Shema T, Topp A, Walter A, Wittwer MB, Wolfard J, Kuhn B, van der Stelt M, Martin RE, Grether U, Schneider G.   +23 more
europepmc   +1 more source